Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil patient-controlled analgesia versus pethidine for pain control during oocyte retrieval
NL-OMON26955Active, not recruiting
- Sponsor
- VU University Medical Center
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remifentanil and pethidine (2 arms), sponsored by VU University Medical Center. Primary endpoints: Pain during oocyte retrieval, Physiologic safety during oocyte retrieval and 2 more. Started May 2010; status: active, not recruiting.
02
Drugs
remifentanilpethidine
Beyond the preview
Go deeper on NL-OMON26955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26955.